|
시장보고서
상품코드
2055206
고분자 바이오소재 시장 : 제품별, 용도별, 지역별Polymeric Biomaterials Market, By Product, By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Neurology and Others), By Geography |
||||||
고분자 바이오소재 시장은 2026년에 766억 2,000만 달러로 추정되며, 2033년까지 1,952억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 14.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 766억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 14.30% | 2033년 시장 규모 예측 : | 1,952억 7,000만 달러 |
고분자 바이오소재란 생체 적합성을 갖추고 의료 용도나 의료기기에 사용되는 고분자를 말합니다. 생분해성 및 생체적합성이라는 특성 덕분에 조직공학 및 재생의학 분야에서 중요한 역할을 하고 있습니다. 고분자 바이오소재에는 콜라겐이나 엘라스틴과 같은 천연 고분자, 또는 폴리글리콜산(PGA), 폴리젖산(PLA), 폴리카프로락톤(PCL)과 같은 합성 고분자가 포함됩니다. 이러한 고분자들은 조절 가능한 물리화학적 특성과 분해 거동을 갖추고 있어, 약물 전달 매체, 의료용 임플란트 및 조직 재생용 스캐폴드로 유망한 후보로 떠오르고 있습니다. 심혈관, 정형외과, 치과, 상처 치유 등 각 분야에서 폴리머계 생체재료의 사용이 증가함에 따라, 전 세계 폴리머계 생체재료 시장은 놀라운 속도로 성장하고 있습니다.
시장 역학
세계 고분자계 생체재료 시장은 주로 만성 질환 유병률의 상승, 고령 인구 증가, 의료용 임플란트 및 조직공학 시술 증가에 힘입어 성장하고 있습니다. 유엔에 따르면, 65세 이상 인구는 2021년 7억 300만 명에서 2050년까지 15억 명으로 증가할 것으로 예측됩니다. 고령화가 진행됨에 따라 임플란트, 조직 스캐폴드 및 기타 의료 용도로 사용되는 고분자 바이오소재 수요가 확대될 것으로 예측됩니다. 또한, 분해 특성을 조절할 수 있는 새로운 생체 흡수성 폴리머의 개발, 가공 기술의 다양화, 그리고 재생 의학에 관한 연구의 진전 또한 시장 성장을 뒷받침하고 있습니다. 그러나 엄격한 규제 승인 절차와 연구 개발(R&D)에 따른 높은 비용이 시장 확대를 저해할 가능성이 있습니다. 그럼에도 불구하고, 신흥국에서의 의료 투자 확대와 의료 기술의 지속적인 발전으로 인해 예측 기간 동안 새로운 기회가 창출될 것으로 전망됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 폴리머 생체재료 시장의 주요 기업 프로파일을 소개합니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 고분자 바이오소재 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 고분자계 생체재료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 고분자 바이오소재 시장 : 제품별, 2021년-2033년
제5장 세계의 고분자 바이오소재 시장 : 용도별, 2021년-2033년
제6장 세계의 고분자 바이오소재 시장 : 지역별, 2021년-2033년
제7장 경쟁 구도
제8장 섹션
LSH 26.06.22Polymeric Biomaterials Market is estimated to be valued at USD 76.62 Bn in 2026 and is expected to reach USD 195.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 76.62 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.30% | 2033 Value Projection: | USD 195.27 Bn |
Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.
Market Dynamics
Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2021 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global polymeric biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market.
Market Segmentation
- Global Polymeric Biomaterials Market, By Product (Revenue, USD Bn, 2021 - 2033)
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polyurethanes
- Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
- Polyaryletheretherketone (PEEK)
- Polydioxanone (PDO)
- Others
- Global Polymeric Biomaterials Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular
- Bioresorbable Stents
- Vascular Grafts
- Sensors
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Dental Sutures
- Others
- Orthopedic
- Joint Replacement Polymeric Biomaterials
- Tissue Fixation Products
- Suture Anchors
- Others
- Orthobiologics
- Viscosupplementation
- Spine Biomaterials
- Others
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Sutures
- Others
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold For CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
- Global Polymeric Biomaterials Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Polymeric Biomaterials Market
- Stryker
- BASF SE
- Evonik Industries AG
- DSM
- Bezwada Biomedical, LLC
- Corbion
- Victrex plc (Invibio Ltd.)
- International Polymer Engineering
- Covalon Technologies Ltd.
- Medtronic
- Abbott
- Elixir Medical
- REVA Medical, LLC
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Polymeric Biomaterials Market, By Product
- Global Polymeric Biomaterials Market, By Application
- Global Polymeric Biomaterials Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing orthopedic and dental applications
- Stringent regulatory environment
- Emerging markets in Asia Pacific and Latin America
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Polymeric Biomaterials Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Polylactic Acid (PLA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Polyglycolic Acid (PGA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Polyurethanes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Polyaryletheretherketone (PEEK)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Polydioxanone (PDO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
5. Global Polymeric Biomaterials Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Bioresorbable Stents
- Vascular Grafts
- Sensors
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Others
- Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Dental Sutures
- Others
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Joint Replacement Polymeric Biomaterials
- Tissue Fixation Products
- Suture Anchors
- Others
- Orthobiologics
- Viscosupplementation
- Spine Biomaterials
- Others
- Plastic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Sutures
- Others
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold For CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
6. Global Polymeric Biomaterials Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Company Profile
- Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BASF SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Evonik Industries AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DSM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bezwada Biomedical, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Corbion
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- Victrex plc (Invibio Ltd.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- International Polymer Engineering
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Covalon Technologies Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elixir Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- REVA Medical, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Meril Life Sciences Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Stryker
- Analyst Views
8. Section
- References
- Research Methodology
- About us
